"Our analysis of a large national database revealed that adding radiation therapy
to androgen-deprivation therapy decreased the risk of death in these
patients by 50 percent over five years," says Jason Efstathiou, MD,
DPhil, of the MGH Cancer Center and Department of Radiation Oncology,
senior author of the study. "It appears that more aggressive local
management of prostate cancer confined to the pelvis can offer more
durable disease control, prevent the disease from spreading further and,
for some patients, even provide a potential cure."
"Our analysis of a large national database revealed that adding radiation therapy
to androgen-deprivation therapy decreased the risk of death in these
patients by 50 percent over five years," says Jason Efstathiou, MD,
DPhil, of the MGH Cancer Center and Department of Radiation Oncology,
senior author of the study. "It appears that more aggressive local
management of prostate cancer confined to the pelvis can offer more
durable disease control, prevent the disease from spreading further and,
for some patients, even provide a potential cure."
No comments:
Post a Comment